Related Experiment Video
Updated: Aug 28, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Knockdown of RhoQ, a member of Rho GTPase, accelerates TGF-β-induced EMT in human lung adenocarcinoma
Kotone Satoh1, Satoshi Sakai2, Makoto Nishizuka1
1Department of Applied Biology and Food Sciences, Faculty of Agriculture and Life Science, Hirosaki University, 3 Bunkyo-cho, Hirosaki, Aomori, 036-8561, Japan.
Abstract:
Lung cancer is the leading cause of cancer-related deaths worldwide, and the most common subtype of lung cancer is adenocarcinoma. RhoQ is a Rho family GTPase with primary sequence and structural similarities to Cdc42 and RhoJ. RhoQ is involved in neurite outgrowth via membrane trafficking and is essential for insulin-stimulated glucose uptake in mature adipocytes. However, the function of RhoQ in lung adenocarcinoma (LUAD) remains unclear. In this study, RhoQ siRNAs were introduced into A549 and PC-9 cells. Expression level of EMT-related genes and invasion ability were investigated using Western blot and transwell assay. To examine the relationship between RhoQ expression and prognosis of LUAD, Kaplan-Meier plotter was used. We discovered that suppressing RhoQ expression promoted TGF-β-mediated EMT and invasion in LUAD cell lines. Furthermore, RhoQ knockdown increased Smad3 phosphorylation and Snail expression, indicating that RhoQ was involved in TGF/Smad signaling during the EMT process. Moreover, Kaplan-Meier plotter analysis revealed that low RhoQ levels were associated with poor overall survival in patients with LUAD. In conclusion, these findings shed light on RhoQ's role as a negative regulator of TGF-β-mediated EMT in LUAD.
Insights
RhoQ suppresses epithelial-mesenchymal transition (EMT) and invasion in lung adenocarcinoma (LUAD). Low RhoQ levels correlate with poor patient survival, highlighting its potential as a therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Lung adenocarcinoma (LUAD) is a leading cause of cancer mortality.
- RhoQ, a Rho family GTPase, has known roles in cell motility and metabolism, but its function in LUAD is unknown.
Purpose of the Study:
- To investigate the role of RhoQ in the progression of lung adenocarcinoma.
- To determine the relationship between RhoQ expression and patient prognosis.
Main Methods:
- RhoQ was suppressed using siRNA in LUAD cell lines (A549, PC-9).
- Epithelial-mesenchymal transition (EMT) markers, cell invasion, and TGF/Smad signaling pathway components were analyzed via Western blot and transwell assays.
- Kaplan-Meier plotter was used to assess the correlation between RhoQ expression and LUAD patient survival.
Main Results:
- RhoQ suppression enhanced TGF-β-induced EMT and invasion in LUAD cells.
- Knockdown of RhoQ led to increased Smad3 phosphorylation and Snail expression, implicating RhoQ in TGF/Smad signaling.
- Low RhoQ expression was significantly associated with poorer overall survival in LUAD patients.
Conclusions:
- RhoQ acts as a negative regulator of TGF-β-mediated EMT and invasion in lung adenocarcinoma.
- RhoQ may serve as a prognostic biomarker and a potential therapeutic target for LUAD.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
TGF - β Signaling Pathway
Cell Polarization by Rho Proteins
The Ras Gene
Ras is a...

